UPDATE 1-FDA approves Novartis's advanced skin cancer drug
July 24, 2015 at 13:06 PM EDT
July 24 (Reuters) - The U.S. Food and Drug Administration approved Novartis AG's oral pill to treat the most common form of advanced skin cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.